Exicure (XCUR) Non-Current Deferred Tax Liability (2024 - 2026)
Exicure's (XCUR) quarterly Non-Current Deferred Tax Liability came in at $423000.0 in Q1 2026, little changed on a QoQ basis from $423000.0 in Q4 2025.
Exicure (XCUR) Non-Current Deferred Tax Liability (2024 - 2026) Analysis & Trends
Exicure (XCUR) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $423000.0 in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $423000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $423000.0 (changed N/A YoY) and the FY2025 annual result came in at $423000.0, up 220.45% from the prior year.
- Non-Current Deferred Tax Liability held at $423000.0 in Q1 2026, from $423000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $423000.0 in Q4 2025 to a low of $132000.0 in Q4 2024.
- A 3-year average of $326000.0 and a median of $423000.0 in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- The widest YoY moves for Non-Current Deferred Tax Liability: up 220.45% in 2025, down 220.45% in 2025.
- Tracing XCUR's Non-Current Deferred Tax Liability over 3 years: stood at $132000.0 in 2024, then surged by 220.45% to $423000.0 in 2025, then changed by 0.0% to $423000.0 in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $423000.0 (Q1 2026), $423000.0 (Q4 2025), and $132000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 423,000.00 |
| Mar 31, 2026 | 423,000.00 |
| Dec 31, 2025 | 423,000.00 |
| Dec 31, 2025 | 423,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Dec 31, 2024 | 132,000.00 |